Company / Operating Margin
Supernus Pharmaceuticals, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-8.7%
FY2025
5-year range
-8.7% / 14.8%
FY2021-FY2025
Trend
-170.2%
vs FY2024
Sector context
#57 of 136
Health Care
What the data says
At -8.7%, Supernus Pharmaceuticals, Inc.'s operating margin ranks #57 of 136 in the Health Care sector. Operating Margin has fluctuated over the past 10 years, ranging from -8.7% in FY2025 to 173.8% in FY2019.
Based on SEC 10-K filings.
-8.7% in FY2025 with a 5-year CAGR of -42.0%.
Declined from -0.9% to -8.7% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -15.6pp
- 5-Year Change
- -42.0pp
- 10-Year Change
- -
Sector benchmark
#57 of 136 in Health CareTop 42% of 136This company -8.7% Sector average -778.9%
▼
+98.9% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 170.2% year-over-year.
- Currently 770.3pp above the Health Care sector average.
- Peak operating margin was recorded in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -8.7% | -170.2% |
| FY2024 | 12.3% | +1522.8% |
| FY2023 | -0.9% | -112.6% |
| FY2022 | 6.9% | -53.4% |
| FY2021 | 14.8% | -55.5% |
| FY2020 | 33.4% | -80.8% |
| FY2019 | 173.8% | +589.2% |
| FY2018 | 25.2% | +78.5% |
| FY2017 | 14.1% | +348.3% |
| FY2016 | -5.7% | -140.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026